New Zealand markets closed

Sanofi (SNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
49.03+1.20 (+2.51%)
At close: 04:00PM EDT
48.10 -0.93 (-1.90%)
After hours: 06:31PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close47.83
Open48.14
Bid49.01 x 400
Ask49.07 x 200
Day's range48.12 - 49.07
52-week range42.63 - 55.72
Volume1,778,020
Avg. volume1,989,433
Market cap122.545B
Beta (5Y monthly)0.44
PE ratio (TTM)25.02
EPS (TTM)1.96
Earnings date25 Jul 2024
Forward dividend & yield2.04 (4.26%)
Ex-dividend date09 May 2024
1y target est59.12
  • Zacks

    FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD

    Per the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication constitutes a major amendment to its previously-submitted data. A final decision is expected by Sep 27.

  • Zacks

    Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More

    J&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority Review tags to Sanofi's (SNY) and Roche's (RHHBY) regulatory applications.

  • GlobeNewswire

    Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan

    Sanofi launches 2024 global Employee Stock Purchase Plan Paris, May 31, 2024. Sanofi’s global employee shareholder plan, Action 2024, opens on June 4, 2024, to around 80,000 employees in 56 countries. Now in its 10th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to secure that employees benefit from the company growth and success. Paul HudsonChief Executive Officer of Sanofi “This plan underscores our ongoing commitment to unite the people of Sanofi b